Julie Parsonnet
Julie Parsonnet
Verified email at
Cited by
Cited by
Helicobacter pylori infection and the risk of gastric carcinoma
J Parsonnet, GD Friedman, DP Vandersteen, Y Chang, JH Vogelman, ...
New England Journal of Medicine 325 (16), 1127-1131, 1991
Helicobacter pylori infection and gastric lymphoma
J Parsonnet, S Hansen, L Rodriguez, AB Gelb, RA Warnke, E Jellum, ...
New England Journal of Medicine 330 (18), 1267-1271, 1994
The epidemiology of tuberculosis in San Francisco--a population-based study using conventional and molecular methods
PM Small, PC Hopewell, SP Singh, A Paz, J Parsonnet, DC Ruston, ...
New England Journal of Medicine 330 (24), 1703-1709, 1994
Helicobacter pylori Virulence and Genetic Geography
A Covacci, JL Telford, GD Giudice, J Parsonnet, R Rappuoli
Science 284 (5418), 1328-1333, 1999
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials
J Parsonnet, RA Harris, HM Hack, DK Owens
The Lancet 348 (9021), 150-154, 1996
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
J Parsonnet, GD Friedman, N Orentreich, H Vogelman
Gut 40 (3), 297-301, 1997
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts
Helicobacter and Cancer Collaborative Group
Gut 49 (3), 347-353, 2001
Helicobacter pylori in peptic ulcer disease
T Yamada, JG Searle, D Ahnen, DH Aipers, HB Greenberg, M Gray, ...
Jama 272 (1), 65-69, 1994
The incidence of Helicobacter pylori infection.
J Parsonnet
Alimentary pharmacology & therapeutics 9, 45-51, 1995
Fecal and oral shedding of Helicobacter pylori from healthy infected adults
J Parsonnet, H Shmuely, T Haggerty
Jama 282 (23), 2240-2245, 1999
Parasitism by the
MJ Blaser, J Parsonnet
The Journal of clinical investigation 94 (1), 4-8, 1994
Helicobacter pylori Infection in Intestinal- and Diffuse-Type Gastric Adenocarcinomas
J Parsonnet, D Vandersteen, J Goates, RK Sibley, J Pritikin, Y Chang
JNCI: Journal of the National Cancer Institute 83 (9), 640-643, 1991
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists
J Parsonnet, MJ Blaser, GI Perez-Perez, N Hargrett-Bean, RV Tauxe
Gastroenterology 102 (1), 41-46, 1992
Antimicrobial resistance incidence and risk factors among Helicobacter pylori–infected persons, United States
WM Duck, J Sobel, JM Pruckler, Q Song, D Swerdlow, C Friedman, ...
Center for Disease Control and Prevention, 2004
Gastrin and colorectal cancer: a prospective study
CM Thorburn, GD Friedman, CJ Dickinson, JH Vogelman, N Orentreich, ...
Gastroenterology 115 (2), 275-280, 1998
Helicobacter pylori and gastric cancer
J Parsonnet
Gastroenterology Clinics of North America 22 (1), 89-104, 1993
Helicobacter pylori and gastric adenocarcinoma
V Herrera, J Parsonnet
Clinical Microbiology and Infection 15 (11), 971-976, 2009
H pylori and gastric cancer
D Forman, P Webb, J Parsonnet
The Lancet 343 (8891), 243-244, 1994
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
S Anand, M Montez-Rath, J Han, J Bozeman, R Kerschmann, P Beyer, ...
The Lancet 396 (10259), 1335-1344, 2020
Vitamin D deficiency and tuberculosis progression
N Talat, S Perry, J Parsonnet, G Dawood, R Hussain
Emerging infectious diseases 16 (5), 853, 2010
The system can't perform the operation now. Try again later.
Articles 1–20